1. Home
  2. NBIX vs DUOL Comparison

NBIX vs DUOL Comparison

Compare NBIX & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • DUOL
  • Stock Information
  • Founded
  • NBIX 1992
  • DUOL 2011
  • Country
  • NBIX United States
  • DUOL United States
  • Employees
  • NBIX N/A
  • DUOL N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • DUOL Computer Software: Prepackaged Software
  • Sector
  • NBIX Health Care
  • DUOL Technology
  • Exchange
  • NBIX Nasdaq
  • DUOL Nasdaq
  • Market Cap
  • NBIX 14.4B
  • DUOL 13.3B
  • IPO Year
  • NBIX 1996
  • DUOL 2021
  • Fundamental
  • Price
  • NBIX $149.66
  • DUOL $196.23
  • Analyst Decision
  • NBIX Strong Buy
  • DUOL Buy
  • Analyst Count
  • NBIX 18
  • DUOL 18
  • Target Price
  • NBIX $172.06
  • DUOL $352.87
  • AVG Volume (30 Days)
  • NBIX 1.0M
  • DUOL 1.8M
  • Earning Date
  • NBIX 10-28-2025
  • DUOL 11-05-2025
  • Dividend Yield
  • NBIX N/A
  • DUOL N/A
  • EPS Growth
  • NBIX 12.44
  • DUOL N/A
  • EPS
  • NBIX 4.19
  • DUOL 0.30
  • Revenue
  • NBIX $2,682,700,000.00
  • DUOL $209,550,000.00
  • Revenue This Year
  • NBIX $23.68
  • DUOL $38.90
  • Revenue Next Year
  • NBIX $18.02
  • DUOL $25.89
  • P/E Ratio
  • NBIX $36.93
  • DUOL $651.33
  • Revenue Growth
  • NBIX 19.61
  • DUOL N/A
  • 52 Week Low
  • NBIX $84.23
  • DUOL $182.00
  • 52 Week High
  • NBIX $157.67
  • DUOL $544.93
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 58.69
  • DUOL 21.81
  • Support Level
  • NBIX $133.62
  • DUOL $182.00
  • Resistance Level
  • NBIX $157.67
  • DUOL $268.97
  • Average True Range (ATR)
  • NBIX 4.57
  • DUOL 13.79
  • MACD
  • NBIX 0.96
  • DUOL -11.16
  • Stochastic Oscillator
  • NBIX 66.69
  • DUOL 9.89

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.

Share on Social Networks: